Jonathan Gill
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Sarcoma Diagnosis and Treatment 33
- Oncology 36
- CAR-T cell therapy research 11
- Cancer Cells and Metastasis 6
- HER2/EGFR in Cancer Research 5
- Co-authors
- Richard Görlick (54 shared papers)David S. Geller (28 shared papers)Douglas J. Harrison (12 shared papers)Valerae O. Lewis (3 shared papers)Michael Roth (36 shared papers)Sajida Piperdi (16 shared papers)Katherine A. Janeway (6 shared papers)Bang H. Hoang (15 shared papers)
- Journals
- Cancer Research (9 papers)Pediatric Blood & Cancer (8 papers)Journal of Clinical Oncology (6 papers)Sarcoma (4 papers)Scientific Reports (3 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Jonathan Gill
81 papers receiving 3.0k citations
Jonathan Gill's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 824
- Oncology 957
- Pulmonary and Respiratory Medicine 978
- Immunology 451
- Molecular Biology 1.4k
Countries citing papers authored by Jonathan Gill
This map shows the geographic impact of Jonathan Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Gill more than expected).
Fields of papers citing papers by Jonathan Gill
This network shows the impact of papers produced by Jonathan Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Gill. The network helps show where Jonathan Gill may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advancing therapy for osteosarcoma Hit paper breakdown → | 2021 | 559 |
| 2 | Current and future therapeutic approaches for osteosarcoma Hit paper breakdown → | 2017 | 539 |
| 3 | Osteosarcoma Hit paper breakdown → | 2022 | 337 |
| 4 | 2012 | 224 | |
| 5 | 2016 | 213 | |
| 6 | 2013 | 123 | |
| 7 | 1996 | 112 | |
| 8 | 2016 | 73 | |
| 9 | 2015 | 54 | |
| 10 | 2015 | 46 | |
| 11 | 2017 | 45 | |
| 12 | 2022 | 44 | |
| 13 | 2014 | 41 | |
| 14 | 2018 | 37 | |
| 15 | 2018 | 29 | |
| 16 | 2017 | 27 | |
| 17 | 2016 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2011 | 22 |
About Jonathan Gill
Jonathan Gill is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Neurology and Molecular Biology, having authored 84 papers that have together received 3.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (33 papers), Neuroblastoma Research and Treatments (15 papers), CAR-T cell therapy research (11 papers), Cancer Genomics and Diagnostics (9 papers), Bone Tumor Diagnosis and Treatments (9 papers), Virus-based gene therapy research (6 papers), Cancer Cells and Metastasis (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (824 citations), Oncology (957 citations), Pulmonary and Respiratory Medicine (978 citations), Immunology (451 citations) and Molecular Biology (1.4k citations). Jonathan Gill has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Richard Görlick, David S. Geller, Douglas J. Harrison, Valerae O. Lewis, Michael Roth, Sajida Piperdi, Katherine A. Janeway, Bang H. Hoang, Kenneth R. Evans and J. Andrew Livingston. Their work appears in journals such as Cancer Research, Pediatric Blood & Cancer, Journal of Clinical Oncology, Sarcoma and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.